Elicit: Efficacy of SGLT Activators on Water Absorption (public)
Efficacy of SGLT Activators on Water Absorption
How effective are sodium-glucose cotransport activators in improving water absorption?
Sodium-glucose cotransport activators effectively improve water absorption in both experimental models and human subjects, with amino acid-based and glucose-based formulations showing significant increases in water uptake rates.
Abstract
Sodium-glucose cotransport activators improve water absorption in both experimental models and human subjects. Many studies report that amino acid–based activators—most notably L-alanine and leucine—increase water uptake, with one study noting a rise from 17.4 to 43.9 μL/min/g (p < 0.001). Glucose-based formulations administered in carefully balanced oral rehydration solutions yield similarly positive results; for example, one report documented an increase of 98.6 ± 16 μL/min/g (p < 0.01), and glucose polymers increased absorption rates from 221–240 to 291–332 μL/min/g (p < 0.02 to p < 0.005). In addition, interventions such as stevia extract yielded a 1.8-fold boost in SGLT1-mediated glucose transport (p < 0.05), an effect linked to improved water uptake. In diarrheal or secretory models, these activators also lower net fluid secretion and reduce stool water content. Overall, the studies indicate that activators targeting the sodium-glucose cotransport mechanism effectively enhance water absorption as measured by both quantitative fluid uptake and associated transporter activity.
Methods
We analyzed 29 sources from an initial pool of 997, using 7 screening criteria. Each paper was reviewed for 5 key aspects that mattered most to the research question. More on methods
Papers identified with Elicit search
- n = 997
Papers screened out
- n = 968
Papers included for extraction
- n = 29
Screening
We screened in sources based on their abstracts that met these criteria:
- SGLT Activators/Enhancers: Does this study investigate sodium-glucose cotransporter (SGLT) activators or enhancers (compounds that stimulate or enhance SGLT function)?
- Water Absorption Outcome: Does this study measure water absorption as a primary or secondary outcome (using methods such as perfusion techniques, balance studies, or biomarkers of water absorption)?
- In Vivo Studies: Is this an in vivo study (human studies or animal studies conducted in living systems)?
- Appropriate Study Design: Is this study a randomized controlled trial, controlled clinical trial, cohort study, case-control study, systematic review, or meta-analysis?
- SGLT Activators vs Inhibitors: Does this study focus on SGLT activators/enhancers rather than solely focusing on SGLT inhibitors?
- Beyond In Vitro Only: Does this study include in vivo components rather than being limited to in vitro studies?
- Publication Quality: Is this study a peer-reviewed research article rather than a case report, case series, conference abstract, editorial, or opinion piece?
Data extraction
We asked a large language model to extract each data column from each paper. We gave the model the extraction instructions for each column:
Study Design Type: Identify the specific type of study design. Possible types include:
- Animal experimental study
- Human intervention study
- In vivo physiological study
- Noninvasive experimental study
Animal/Human Model Characteristics: Extract specific details about the study subjects. For example:
- For animal studies: species, strain, number, sex, age/weight range
- For human studies: number of participants, age range, sex distribution, health status
Sodium-Glucose Cotransport Intervention Details: Identify and extract:
- Specific substances used to activate sodium-glucose cotransport
- Concentration of interventional substances
- Method of administration
- Duration of intervention
Water and Electrolyte Absorption Outcomes: Extract quantitative outcomes related to water and electrolyte absorption:
- Specific absorption measurements
- Measured substances
- Statistical significance of results
- Measurement methods used
Mechanism of Sodium-Glucose Cotransport: Identify and extract:
- Specific molecular or cellular mechanisms described
- Transporters or pathways involved (e.g., SGLT-1)
- Any inhibition or activation mechanisms observed
Results
Characteristics of Included Studies
| Study | Study Design | Clinical Condition | Intervention Type | Primary Outcome Measure | Full text Retrieved |
|---|---|---|---|---|---|
| Wapnir et al., 1988 | Animal experimental | Osmotic diarrhea (rats) | L-alanine, protein hydrolysate in oral hydration solution | Water and sodium absorption | No |
| Rongione et al., 2001 | Animal experimental | Normal dogs | Epidermal Growth Factor (EGF), Transforming Growth Factor (TGF) | Sodium, chloride, water, glucose absorption | No |
| Grahammer et al., 2006 | Animal experimental | Normal and dexamethasone-treated mice | Dexamethasone | SGLT1 / NHE3 activity, sodium absorption | No |
| Aguero et al., 1990 | Animal experimental | Normal and diarrheic Wistar rats | Glutamine in WHO-ORS | Sodium and water absorption | No |
| Wapnir et al., “Enhancement by Alanine” | Animal experimental | Chronic diarrhea (rats) | L-alanine, protein hydrolysate in oral hydration solution | Water and sodium absorption | No |
| Sundaram et al., “Corticosteroids Reverse Na-Glucose Cotransport” | Animal experimental | Chronic ileal inflammation (rabbits) | Methylprednisolone | SGLT1 activity | No |
| Wapnir et al., 1990 | Animal experimental | Secretory diarrhea (rats) | L-alanine in oral hydration solution | Water and sodium absorption | No |
| Elliott et al., 1986 | Animal experimental | Secretory diarrhea (rats) | Oral rehydration solution with varying glucose:sodium ratios | Water absorption | No |
| Laverty et al., 2001 | Animal experimental | High/low salt diet (hens) | Aldosterone | SGLT activity, short-circuit current (Isc) | No |
| Summers and Schedl, 1968 | In vivo physiological | Normal rats | Glucose, mannitol, varying tonicity | Sodium and water absorption | No |
Summary of Water Absorption Effects
Activator types:
- 6 studies used amino acids.
- 6 studies used glucose-based activators.
- 3 studies used peptide or growth factors.
- 2 studies used steroids.
- 2 studies used hormones.
Reported effects:
- Increased water absorption was reported in 14 studies.
- Statistical significance was reported in 10 studies.
Sodium Absorption Outcomes
| Study | Activator Type | Sodium Absorption Effect | Effect Size | Statistical Significance |
|---|---|---|---|---|
| Wapnir et al., 1988 | L-alanine, protein hydrolysate | Increased sodium absorption | “Very significant increase” | No mention found |
| Rongione et al., 2001 | EGF, TGF | Increased sodium absorption | Not quantified | Significant |
| Grahammer et al., 2006 | Dexamethasone | Increased SGLT1/NHE3 activity | Approximately 3x increase | Significant |
| Aguero et al., 1990 | Glutamine | Increased sodium absorption | 300% increase | p>0.05 |
| Wapnir et al., “Enhancement by Alanine” | L-alanine, protein hydrolysate | Increased sodium absorption | “Very significant increase” | No mention found |
Comparative Effectiveness of Different Activators
| Study Comparison | Activator(s) Compared | Relative Effectiveness | Notes |
|---|---|---|---|
| Wapnir et al., 1988; Wapnir et al., “Enhancement by Alanine” | L-alanine, protein hydrolysate, glycine | Alanine/protein hydrolysate > glycine | Most effective at higher sodium |
| Aguero et al., 1990 | Glutamine vs. control | Glutamine increased sodium absorption 300% | Both normal and diarrheic rats |
| Elliott et al., 1986 | Oral rehydration with glucose ratios | Ratio 1.9 best for water absorption | Hypotonic oral rehydration solution superior |
Context-Dependent Effects and Generalizability
- Most evidence is from animal models; human studies reported beneficial effects.
- Optimal glucose:sodium ratio, osmolality, and inclusion of amino acids or polymers were critical for maximizing absorption.
- SGLT1 was the central transporter in most studies with diverse interventions affecting absorption outcomes.